Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

NCT05181605 is registered in ClinicalTrials.gov with Instituto de investigación e innovación biomédica de Cádiz as lead sponsor.

NCT NCT05181605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05181605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors
Lead sponsor
Instituto de investigación e innovación biomédica de Cádiz
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 15, 2022
Completion date
December 1, 2024
Enrollment
116 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma, pancreatic cancer resectable